Cerecin
PrivateLast Round
Pre Seed
May 9, 2024
Total Funding Raised
$46M
Company Overview
Cerecin is a clinical-stage biotechnology company that develops therapeutics targeting the metabolic basis of central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerecin Comparables
Compare Cerecin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| T3D Therapeutics, Inc. | 78% | |
| AriBio | 70% | |
| Nestlé | 64% |
Cerecin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 9, 2024 | ||||
| Series B Extension | Oct 3, 2022 | ||||
| Series B | Oct 19, 2021 | ||||
| VC Round | Oct 4, 2018 | ||||
| VC Round | Jul 18, 2012 | ||||
Series A | Oct 5, 2004 |
Cerecin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wilmar Ventures | Pre Seed, VC Round |
| Hanwha Investment & Securities | Pre Seed |
| BNK Securities | Pre Seed |
| Linea Investment | Series A |
| IBK Capital | Series B |
| KNT Investment | Series B Extension |
| KB Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 9, 2024
$29M round with participation from Nestlé and Wilmar Ventures.
- Oct 3, 2022
Led by SK Securities and KNT Investment.
Cerecin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cerecin's valuation, stock price, and market status.
Is Cerecin a public or private company?
Cerecin is a private company.
What is the current stock price of Cerecin?
Cerecin is a private company with no public stock price. No recent secondary market data is available.
How much is Cerecin worth (valuation)?
Valuation information for Cerecin is not publicly available.
Can I buy Cerecin stock?
Cerecin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cerecin's last funding round?
Funding round information for Cerecin is not publicly available.
Who are the main investors in Cerecin?
Investor information for Cerecin is not publicly disclosed.
Will Cerecin IPO soon?
No public IPO plans have been announced for Cerecin.
How can I track Cerecin secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cerecin's secondary market activity and sign up for updates.